Increased Bowel Toxicity in Patients Treated With a Vascular Endothelial Growth Factor Inhibitor (VEGFI) After Stereotactic Body Radiation Therapy (SBRT)-Reference-Cited by-同舟云学术

Increased Bowel Toxicity in Patients Treated With a Vascular Endothelial Growth Factor Inhibitor (VEGFI) After Stereotactic Body Radiation Therapy (SBRT)

Published:2013-09 Issue:1 Volume:87 Page:73-80
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Barney Brandon M.,Markovic Svetomir N.,Laack Nadia N.,Miller Robert C.,Sarkaria Jann N.,Macdonald O. Kenneth,Bauer Heather J.,Olivier Kenneth R.

Publisher

Elsevier BV

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology,Radiation

Reference38 articles.

1. Bevacizumab (Avastin), a humanized anti-VEGF monoclonal antibody for cancer therapy;Ferrara;Biochem Biophys Res Commun,2005

2. Sorafenib in advanced clear-cell renal-cell carcinoma;Escudier;N Engl J Med,2007

3. Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma;Friedman;J Clin Oncol,2009

4. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer;Hurwitz;N Engl J Med,2004

5. Phase III trial of cisplatin plus gemcitabine with either placebo or bevacizumab as first-line therapy for nonsquamous non-small-cell lung cancer: AVAil;Reck;J Clin Oncol,2009

Cited by 91 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety and tolerability of radiotherapy in combination with systemic targeted therapies for treatment of hepatocellular carcinoma: a narrative review;Chinese Clinical Oncology;2024-06

2. Concurrent Atezolizumab Plus Bevacizumab and High-Dose External Beam Radiotherapy for Highly Advanced Hepatocellular Carcinoma;The Oncologist;2024-03-26

3. The Role of Targeted Radiation Therapy in the Treatment of Renal Cell Carcinoma;Kidney Cancer;2024-02-16

4. Radiotherapy in the management of lung oligometastases;Cancer/Radiothérapie;2024-02

5. Stereotactic body radiation therapy for liver metastases in oligometastatic disease;Cancer/Radiothérapie;2024-02